Moreover, LDH release and calcium staining assays revealed that the activity of HCC cells was lowest upon addition of NK cells, significantly increased in the IL-22 treatment group, but decreased under the condition of IL-22 plus CD155 silence (Figures 5H, I). Here, IL22 is linked to hepatocellular carcinoma.